The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Neoadjuvant pembrolizumab in surgically resectable, locally advanced HPV negative head and neck squamous cell carcinoma (HNSCC).
 
Ravindra Uppaluri
Consulting or Advisory Role - Merck
Research Funding - Merck
 
Paul Zolkind
No Relationships to Disclose
 
Tianxiang Lin
No Relationships to Disclose
 
Brian Nussenbaum
No Relationships to Disclose
 
Ryan S Jackson
No Relationships to Disclose
 
Jason Rich
No Relationships to Disclose
 
Patrik Pipkorn
No Relationships to Disclose
 
Randal Paniello
No Relationships to Disclose
 
Wade Thorstad
No Relationships to Disclose
 
Loren Michel
No Relationships to Disclose
 
Tenny Mudianto
No Relationships to Disclose
 
Peter John Oppelt
No Relationships to Disclose
 
Tanya Marya Wildes
Honoraria - Carevive Systems
 
Gavin P Dunn
Stock and Other Ownership Interests - Immunovalent Therapeutics
 
Jay F Piccirillo
No Relationships to Disclose
 
Dorina Kallogjeri
No Relationships to Disclose
 
Scott Rodig
Consulting or Advisory Role - Bristol-Myers Squibb
Speakers' Bureau - Bristol-Myers Squibb
Research Funding - Bristol-Myers Squibb
Travel, Accommodations, Expenses - Bristol-Myers Squibb
 
Ian S. Hagemann
Consulting or Advisory Role - McKesson; Molecular Health
 
Rebecca Chernock
No Relationships to Disclose
 
Douglas Adkins
Research Funding - Celgene; Cellceutix; Gliknik; Merck; Novartis Pharmaceuticals UK Ltd.; Pfizer